Sleep Number (SNBR) Q4 2025 earnings review
Sales Declines Soften, But Liquidity Pressures Force Strategic Review
Sleep Number's turnaround yielded a highly volatile Q4. Revenue fell 8% YoY to $347 million, a notable deceleration in top-line contraction compared to the ~20% declines seen earlier in 2025. The company realized $185 million in annualized cost savings, helping Adjusted EBITDA reach $19 million. The new ComfortMode bed launch is also showing strong early traction. However, aggressive clearance of existing products severely impacted liquidity, and the bottom line collapsed: Net Loss spiked to $59 million (EPS -$2.55) driven by a massive $47.9 million deferred tax valuation adjustment and a $9.6 million inventory write-down. The most critical development is the engagement of Guggenheim Securities to evaluate options for the company's credit facility and capital structure—a glaring signal of balance sheet stress.
🐂 Bull Case
The Q4 top-line decline of 8% is a clear improvement over previous quarters. The newly launched ComfortMode bed is outselling plans by 3.5x with stronger margins than the products it replaces, indicating the shortened 10-month R&D cycle is paying off.
Management successfully implemented $185 million in annualized cost reductions in 2025 and announced plans for another $50 million in fixed cost savings for 2026. This creates a highly levered operational base once sales return to positive growth.
🐻 Bear Case
The engagement of an investment bank (Guggenheim) to address the capital structure implies the company is uncomfortably close to the edge. The leverage ratio sits at 4.1x EBITDAR, perilously close to the 4.5x covenant maximum.
GAAP Net Loss ballooned to $59 million. The $47.9 million deferred tax valuation adjustment and $9.6 million inventory obsolescence charge highlight the immense friction costs of executing this turnaround.
⚖️ Verdict: 🔴
Bearish. While the deceleration in revenue decline and rapid product traction are genuinely positive operational signals, retaining investment bankers to evaluate the balance sheet is a definitive red flag. Survival mechanics are currently overshadowing fundamental improvements.
Key Themes
Capital Structure Review Highlights Liquidity Crunch
Despite beating Adjusted EBITDA guidance, management explicitly stated that industry headwinds and product clearance activities had an 'outsized impact' on liquidity. Engaging Guggenheim Securities indicates the company likely needs debt restructuring, covenant relief, or a highly dilutive capital raise to survive the final phases of its turnaround. Revolving credit facility borrowings have grown persistently every quarter in 2025.
ComfortMode Launch Validates Product Reset
A primary growth driver is the completely overhauled product portfolio, developed in just 10 months (vs a historical 2-year cycle). The ComfortMode bed, launched in January, is outselling internal plans by 3.5x. Importantly, management noted these beds carry stronger margins than the legacy models they replace, providing a dual driver for both sales and gross margin recovery.
Cost Structure Transformation Enables Leverage
The company has successfully executed $185 million of annualized cost reductions, touching G&A, real estate, technology, and corporate structure. By stripping these costs, Sleep Number exited FY25 with a pro-forma Adjusted EBITDA margin of 9%. The addition of another $50 million in fixed cost cuts planned for 2026 sets the stage for dramatic margin expansion if top-line growth reverses to positive.
Macro Headwinds Anchor Top-Line Pressures
Management continues to cite 'ongoing industry demand pressure and lower store traffic' as a dominant headwind. The macroeconomic picture for large-ticket durables remains poor. Even with the 53rd week acting as a tailwind in Q4, retail comparable-store sales still plunged 15% when adjusted.
Positive Cost Narrative Contradicted by Cash Burn
Management aggressively touted $185 million in cost savings and ending the year with an annualized pro forma EBITDA margin of 9%. However, Free Cash Flow remains negative. Full-year Net Cash used in operations was $3 million, and Free Cash Flow was a use of $18 million (down $21 million YoY). True cash generation has not yet followed the non-GAAP profitability narrative.
Other KPIs
Stable/Decelerating. Adjusted for the extra 53rd week in FY25, Q4 comparable store sales fell 15%. This marks a modest improvement from the -19% trough in Q3 and -18% in Q2, but indicates core consumer traffic remains severely depressed.
Decelerating. GAAP gross margin dropped steeply from 59.9% a year ago. The primary culprit was a $9.6 million inventory obsolescence charge linked to the accelerated rollout of the new product line. Excluding this charge, adjusted gross margin would have been a healthier 58.4%.
Guidance
Accelerating. Management expects double-digit growth off the FY25 base of $78 million. This will be driven by the full-year realization of the $185M cost cuts, $50M in new cuts, and margin uplift from the new product portfolio.
Reversing. The company projects an inflection point in the second half of 2026, pivoting from the persistent contraction seen over the last two years to positive topline growth. This hinges entirely on the macro environment stabilizing and the success of the remaining product launches in March.
Stable. The company is continuing its aggressive cost-cutting regime, identifying another $50 million in annualized fixed cost savings to be implemented over the coming year.
Key Questions
Guggenheim Mandate Options
With the engagement of Guggenheim Securities, what specific capital structure mechanisms are being prioritized? Are you leaning toward covenant amendments with current lenders, taking on alternative financing, or considering dilutive equity issuance?
Deferred Tax Valuation Trigger
Can you provide the precise operational or forward-looking triggers that forced the massive $47.9 million deferred tax valuation adjustment this quarter?
ComfortMode Cannibalization
The ComfortMode bed is outselling plans by 3.5x, but to what degree is this cannibalizing sales of the legacy lineup versus bringing net-new customers into the ecosystem?
Liquidity Runway
Given that Free Cash Flow was -$18 million for the year and revolving credit borrowings sit at $588 million, what is the absolute minimum level of sales required in H1 2026 to avoid a liquidity shortfall before the guided H2 growth inflection materializes?